UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 6, pp. 511 - 522
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Single-Blind Method | Glucocorticoids - administration & dosage | Myasthenia Gravis - classification | Prednisone - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Hospitalization | Young Adult | Thymectomy | Adolescent | Adult | Female | Aged | Myasthenia Gravis - drug therapy | Myasthenia Gravis - surgery | Treatment outcome | Usage | Care and treatment | Myasthenia gravis | Analysis | Clinical trials | Prednisone | Dosage and administration | Lymphatic system | Neuromuscular diseases | Patients | Evidence-based medicine | Quality of life | Neurological diseases | Immunosuppression | Surgery | Neuromuscular junctions | Myasthenia | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 1, pp. 32 - 43
RANDOMIZED CONTROLLED TRIAL | POPULATION | HOSPITALIZED-PATIENTS | RISK | NATIONAL REGISTRY ADHERE | OUTCOMES | DIURETICS | UMCG Approved | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Heart Failure - complications | Natriuretic Peptide, Brain - therapeutic use | Recurrence | Acute Disease | Natriuretic Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Dyspnea - etiology | Hypotension - chemically induced | Natriuretic Peptide, Brain - adverse effects | Heart Failure - drug therapy | Intention to Treat Analysis | Dyspnea - drug therapy | Female | Aged | Kidney Diseases - etiology | Patient Readmission - statistics & numerical data | Natriuretic Agents - therapeutic use | Heart Failure - mortality | Heart failure | Drug therapy | Shortness of breath | Edema | Renal function | Toxicity | Research & development--R&D | Hypotension | Glomerular filtration rate | Studies | Heart rate | Dyspnea | Databases | Death | Respiration | Research centers | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Heart Failure/complications/drug therapy/mortality | Natriuretic Agents/adverse effects/therapeutic use | MEDICIN OCH HÄLSOVETENSKAP | Dyspnea/drug therapy/etiology | Brain/adverse effects/therapeutic use | Hypotension/chemically induced | Kidney Diseases/etiology | Patient Readmission/statistics & numerical data | Natriuretic Peptide | MEDICAL AND HEALTH SCIENCES
Journal Article
JACC. Cardiovascular imaging, ISSN 1936-878X, 06/2015, Volume 8, Issue 6, pp. 656 - 665
Reference ranges | Ethnic appropriate | Echocardiography | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Age Factors | United States | Humans | Middle Aged | Echocardiography - methods | Male | Reference Values | Systole | Heart Atria - diagnostic imaging | Heart Ventricles - diagnostic imaging | Stroke Volume | Young Adult | Ethnic Groups | Adolescent | Sex Factors | Aged, 80 and over | Adult | Female | Ventricular Function, Left - physiology | Aged | Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2009, Volume 157, Issue 4, pp. 606 - 612
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Miscellaneous. Osteoarticular involvement in other diseases | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Medical sciences | Ibuprofen - therapeutic use | Pyrazoles - therapeutic use | Prospective Studies | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Cyclooxygenase Inhibitors - administration & dosage | Ibuprofen - administration & dosage | Treatment Outcome | Celecoxib | Naproxen - therapeutic use | Dose-Response Relationship, Drug | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Naproxen - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Cardiovascular Diseases - epidemiology | Cyclooxygenase Inhibitors - therapeutic use | Sulfonamides - administration & dosage | Medical colleges | Care and treatment | Safety regulations | Cardiovascular agents | Rheumatoid factor | Pain | Analysis | Rheumatoid arthritis | Cardiac patients | Antiarthritic agents | Nonsteroidal anti-inflammatory drugs | Angiogenesis inhibitors | Cardiology | Osteoarthritis | Hypertension | Heart failure | Aspirin | Stroke | Heart attacks | Meetings | Arthritis | Patients | Quality of life | Studies | Blood platelets | Blood pressure | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2011, Volume 364, Issue 1, pp. 11 - 21
SURVIVAL | TRIAL | LEFT-VENTRICULAR DYSFUNCTION | TASK-FORCE | SPIRONOLACTONE | ACUTE MYOCARDIAL-INFARCTION | ALDOSTERONE | CARDIAC FIBROSIS | ASSOCIATION | UMCG Approved | MINERALOCORTICOID RECEPTOR | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Hospitalization - statistics & numerical data | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Combined Modality Therapy | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Cardiovascular Agents - therapeutic use | Heart Failure - classification | Defibrillators, Implantable | Cardiovascular Diseases - mortality | Female | Aged | Spironolactone - analogs & derivatives | Spironolactone - therapeutic use | Spironolactone - adverse effects | Heart Failure - mortality | Heart failure | Diagnosis | Drug therapy | Risk factors | Hospitalization | Heart attacks | Statistical analysis | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases/mortality | Cardiovascular Agents/therapeutic use | Aldosterone Antagonists/adverse effects/therapeutic use | Implantable | Kardiologi | Heart Failure/classification/drug therapy/mortality | Cardiac and Cardiovascular Systems | Spironolactone/adverse effects/analogs & derivatives/therapeutic use | Defibrillators | Hospitalization/statistics & numerical data
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 21, pp. 1993 - 2003
MONICA PROJECT | HEART-DISEASE | ADULTS | LIPODYSTROPHY | HIV-1-INFECTED PATIENTS | EVENT RATES | ASSOCIATION | UMCG Approved | CORONARY-ARTERY-DISEASE | PROTEASE INHIBITORS | HIV-INFECTED PATIENTS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV-1 | Myocardial Infarction - chemically induced | Anti-Retroviral Agents - therapeutic use | Myocardial Infarction - epidemiology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Anti-Retroviral Agents - adverse effects | Male | CD4 Lymphocyte Count | Incidence | Regression Analysis | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | Poisson Distribution | Drug Therapy, Combination | Adverse and side effects | Antiviral agents | Anti-HIV agents | Heart attack | Risk factors | Clinical trials | Therapy | Heart attacks | Metabolism | Human immunodeficiency virus--HIV | Older people | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 21, pp. 1993 - 2003
Journal Article
AIDS (London), ISSN 0269-9370, 2008, Volume 22, Issue 16, pp. 2143 - 2153
D:A:D study | Non-AIDS-defining malignancies | AIDS-defining malignancies | HIV infection | Mortality | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Immunopathology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Age Factors | Drug Administration Schedule | Humans | Middle Aged | Neoplasms - mortality | Male | CD4 Lymphocyte Count | Lymphoma, AIDS-Related - immunology | Anti-HIV Agents - administration & dosage | Young Adult | HIV Infections - immunology | Lymphoma, AIDS-Related - mortality | Neoplasms - virology | Epidemiologic Methods | Neoplasms - immunology | HIV Infections - complications | Sex Factors | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Aged | Immunocompromised Host | Homosexuality, Male - statistics & numerical data | Index Medicus | AIDS/HIV | mortality | non-AIDS-defining malignancies | Medicin och hälsovetenskap
Journal Article